Optimizing Prostate Cancer Treatment: Focal Dose Escalation to the MRI-Defined GTV

This webinar delves into the clinical evidence and rationale behind focal dose escalation to the MRI-defined gross tumor volume (GTV) in prostate cancer, a crucial aspect of effective radiation therapy planning.

Reviewing Real-World Clinical Cases for Best Practices

We’ll examine real clinical cases to learn the optimal methods for identifying and contouring the GTV, enabling radiation oncologists to refine their skills in radiotherapy planning.

Overcoming Dosimetric Constraints and Pitfalls

The webinar will also address common dosimetric constraints and pitfalls, providing valuable insights to help oncologists overcome these challenges and deliver the best possible patient outcomes.

This educational activity is made possible through the support of the ROI Juan A. del Regato Fund, a part of ASTRO’s Research Foundation. Learn more about the ROI’s mission and initiatives at roinstitute.org.

Target Audience and Learning Objectives

This course is specifically designed to cater to the needs of radiation oncologists and radiation oncology residents.

• Upon completion of this live activity, participants will be able to:
• Describe the patient cohort most likely to benefit from a focal boost to the prostate
• Develop a framework for assessing multiparametric prostate MRIs to define a boost
• Practice boost delineation with the opportunity for peer feedback and improvement

This activity will be available from October 19, 2023, through 11:59 p.m. Eastern time on October 18, 2025. Don’t miss this opportunity to enhance your skills and knowledge in prostate cancer treatment.